Concepts (205)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| HIV-1 | 11 | 2020 | 3365 | 1.83 | Why? |
| Retroviridae Infections | 2 | 2018 | 45 | 1.36 | Why? |
| Immunoprecipitation | 2 | 2018 | 300 | 0.84 | Why? |
| Antibodies, Neutralizing | 19 | 2021 | 25288 | 0.81 | Why? |
| Nuclear Pore | 1 | 2018 | 49 | 0.74 | Why? |
| Myxovirus Resistance Proteins | 1 | 2018 | 77 | 0.74 | Why? |
| Vesicular stomatitis Indiana virus | 2 | 2020 | 354 | 0.74 | Why? |
| GC Rich Sequence | 1 | 2017 | 3 | 0.73 | Why? |
| Retroviridae | 1 | 2018 | 49 | 0.72 | Why? |
| Dinucleoside Phosphates | 1 | 2017 | 11 | 0.72 | Why? |
| Moloney murine leukemia virus | 1 | 2017 | 9 | 0.71 | Why? |
| Regulatory Sequences, Nucleic Acid | 1 | 2018 | 95 | 0.70 | Why? |
| gag Gene Products, Human Immunodeficiency Virus | 1 | 2018 | 95 | 0.70 | Why? |
| RNA Splicing | 1 | 2018 | 119 | 0.67 | Why? |
| Receptors, Aryl Hydrocarbon | 1 | 2018 | 152 | 0.64 | Why? |
| Antibody Affinity | 1 | 2021 | 1078 | 0.62 | Why? |
| Mutation | 10 | 2021 | 12376 | 0.62 | Why? |
| Virus Release | 1 | 2017 | 253 | 0.59 | Why? |
| Virus Assembly | 1 | 2018 | 438 | 0.58 | Why? |
| Antibodies, Viral | 16 | 2021 | 51949 | 0.50 | Why? |
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2017 | 624 | 0.47 | Why? |
| Transcription, Genetic | 1 | 2018 | 1326 | 0.47 | Why? |
| Antigens, CD | 1 | 2017 | 984 | 0.45 | Why? |
| Virus Replication | 8 | 2021 | 14331 | 0.45 | Why? |
| Neutralization Tests | 9 | 2021 | 6698 | 0.43 | Why? |
| High-Throughput Nucleotide Sequencing | 2 | 2018 | 3633 | 0.38 | Why? |
| Interferon-gamma | 1 | 2018 | 2711 | 0.36 | Why? |
| RNA, Viral | 5 | 2018 | 32276 | 0.35 | Why? |
| Spike Glycoprotein, Coronavirus | 14 | 2021 | 37182 | 0.34 | Why? |
| Capsid | 2 | 2004 | 197 | 0.30 | Why? |
| Cell Line | 7 | 2021 | 12040 | 0.30 | Why? |
| Mutagenesis | 2 | 2018 | 394 | 0.30 | Why? |
| HIV Infections | 4 | 2018 | 11620 | 0.29 | Why? |
| Protein Binding | 5 | 2021 | 11430 | 0.29 | Why? |
| Immunoassay | 1 | 2020 | 4485 | 0.28 | Why? |
| Host-Pathogen Interactions | 3 | 2021 | 11041 | 0.27 | Why? |
| Epitopes | 5 | 2021 | 4113 | 0.25 | Why? |
| Cyclophilin A | 1 | 2003 | 90 | 0.25 | Why? |
| Antiviral Agents | 4 | 2018 | 41703 | 0.23 | Why? |
| Antibodies, Monoclonal | 10 | 2021 | 8041 | 0.22 | Why? |
| Virion | 3 | 2017 | 1444 | 0.22 | Why? |
| Chimera | 1 | 2020 | 83 | 0.22 | Why? |
| Base Sequence | 2 | 2020 | 3581 | 0.22 | Why? |
| Viral Vaccines | 2 | 2021 | 7560 | 0.21 | Why? |
| RNA, Messenger | 3 | 2021 | 5131 | 0.21 | Why? |
| Biological Variation, Population | 1 | 2020 | 69 | 0.21 | Why? |
| Antibodies, Monoclonal, Murine-Derived | 1 | 2021 | 94 | 0.21 | Why? |
| Vesiculovirus | 1 | 2020 | 153 | 0.21 | Why? |
| RNA-Binding Proteins | 2 | 2018 | 1022 | 0.20 | Why? |
| Camelids, New World | 1 | 2021 | 276 | 0.20 | Why? |
| Protein Isoforms | 1 | 2020 | 347 | 0.20 | Why? |
| Cyclins | 1 | 2018 | 16 | 0.19 | Why? |
| SAM Domain and HD Domain-Containing Protein 1 | 1 | 2018 | 20 | 0.19 | Why? |
| Genes, Reporter | 1 | 2020 | 472 | 0.19 | Why? |
| Antibodies, Bispecific | 1 | 2021 | 207 | 0.19 | Why? |
| Cyclin-Dependent Kinases | 1 | 2018 | 124 | 0.18 | Why? |
| Nuclear Pore Complex Proteins | 1 | 2018 | 53 | 0.18 | Why? |
| Reassortant Viruses | 1 | 2020 | 287 | 0.18 | Why? |
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2018 | 76 | 0.18 | Why? |
| Virus Internalization | 1 | 2017 | 7921 | 0.18 | Why? |
| Viral Proteins | 1 | 2017 | 7370 | 0.18 | Why? |
| Thymocytes | 1 | 2017 | 11 | 0.18 | Why? |
| NIH 3T3 Cells | 1 | 2017 | 147 | 0.17 | Why? |
| HEK293 Cells | 3 | 2020 | 8394 | 0.17 | Why? |
| Cell Cycle | 1 | 2018 | 329 | 0.17 | Why? |
| Cyclohexanes | 1 | 2017 | 43 | 0.17 | Why? |
| Immunoglobulin Fab Fragments | 1 | 2020 | 556 | 0.16 | Why? |
| Simian Acquired Immunodeficiency Syndrome | 1 | 2018 | 154 | 0.16 | Why? |
| RNA Stability | 1 | 2018 | 285 | 0.16 | Why? |
| Models, Molecular | 5 | 2021 | 7616 | 0.16 | Why? |
| Selection, Genetic | 1 | 2020 | 691 | 0.16 | Why? |
| STAT1 Transcription Factor | 1 | 2018 | 313 | 0.16 | Why? |
| Nucleotides | 1 | 2018 | 212 | 0.16 | Why? |
| Cytoplasm | 1 | 2017 | 304 | 0.15 | Why? |
| Macrophage Activation | 1 | 2018 | 315 | 0.15 | Why? |
| Gene Knockout Techniques | 1 | 2017 | 347 | 0.15 | Why? |
| GPI-Linked Proteins | 1 | 2017 | 317 | 0.15 | Why? |
| Animals | 12 | 2021 | 78931 | 0.15 | Why? |
| Capsid Proteins | 1 | 2018 | 365 | 0.15 | Why? |
| HIV Envelope Protein gp120 | 1 | 2017 | 267 | 0.14 | Why? |
| Immunoglobulin A | 3 | 2021 | 3567 | 0.14 | Why? |
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 2 | 2004 | 7 | 0.14 | Why? |
| Phosphorylation | 1 | 2018 | 1060 | 0.14 | Why? |
| Structure-Activity Relationship | 1 | 2021 | 2219 | 0.14 | Why? |
| Proteins | 2 | 2018 | 921 | 0.14 | Why? |
| Hematopoietic Stem Cells | 1 | 2017 | 321 | 0.14 | Why? |
| B-Lymphocytes | 4 | 2021 | 4418 | 0.13 | Why? |
| Virulence | 1 | 2021 | 2172 | 0.13 | Why? |
| Single-Domain Antibodies | 1 | 2021 | 744 | 0.13 | Why? |
| Recombination, Genetic | 1 | 2020 | 1265 | 0.13 | Why? |
| Protein Domains | 3 | 2021 | 6563 | 0.13 | Why? |
| Cell Line, Tumor | 2 | 2020 | 3608 | 0.13 | Why? |
| Viral Regulatory and Accessory Proteins | 1 | 2018 | 482 | 0.13 | Why? |
| Spleen | 1 | 2017 | 877 | 0.12 | Why? |
| Binding Sites | 3 | 2021 | 6201 | 0.12 | Why? |
| Triazoles | 1 | 2017 | 440 | 0.12 | Why? |
| Humans | 31 | 2021 | 930598 | 0.12 | Why? |
| Cells, Cultured | 2 | 2018 | 5835 | 0.11 | Why? |
| Protein Conformation | 1 | 2021 | 4386 | 0.10 | Why? |
| Somatic Hypermutation, Immunoglobulin | 2 | 2021 | 283 | 0.10 | Why? |
| Immunization, Passive | 3 | 2020 | 10067 | 0.10 | Why? |
| Mice, Transgenic | 1 | 2017 | 2739 | 0.10 | Why? |
| Mice | 5 | 2021 | 21357 | 0.10 | Why? |
| Viremia | 1 | 2017 | 1020 | 0.10 | Why? |
| Immunoglobulin G | 4 | 2021 | 21571 | 0.10 | Why? |
| Viral Tropism | 1 | 2017 | 1329 | 0.10 | Why? |
| Cryoelectron Microscopy | 3 | 2021 | 2372 | 0.09 | Why? |
| Simian Immunodeficiency Virus | 2 | 2017 | 251 | 0.09 | Why? |
| Molecular Sequence Data | 2 | 2004 | 3198 | 0.09 | Why? |
| Vaccines, Synthetic | 1 | 2021 | 3231 | 0.09 | Why? |
| Immune System | 1 | 2017 | 1479 | 0.08 | Why? |
| Antigens, Viral | 2 | 2021 | 6298 | 0.08 | Why? |
| Vero Cells | 2 | 2020 | 14117 | 0.08 | Why? |
| Macrophages | 1 | 2018 | 2784 | 0.08 | Why? |
| Serologic Tests | 1 | 2020 | 4359 | 0.08 | Why? |
| Immunity, Humoral | 1 | 2021 | 4849 | 0.08 | Why? |
| Genome, Viral | 2 | 2018 | 13157 | 0.08 | Why? |
| Gene Expression Regulation | 1 | 2018 | 4020 | 0.07 | Why? |
| Longitudinal Studies | 1 | 2021 | 9893 | 0.07 | Why? |
| Protein Multimerization | 2 | 2021 | 1336 | 0.07 | Why? |
| Immunologic Memory | 3 | 2021 | 3362 | 0.07 | Why? |
| Aotidae | 1 | 2003 | 14 | 0.07 | Why? |
| Gene Products, gag | 1 | 2003 | 28 | 0.07 | Why? |
| Betacoronavirus | 4 | 2021 | 204454 | 0.07 | Why? |
| Leukemia Virus, Murine | 1 | 2003 | 38 | 0.07 | Why? |
| Receptors, Virus | 1 | 2020 | 5659 | 0.06 | Why? |
| Host-Parasite Interactions | 1 | 2003 | 112 | 0.06 | Why? |
| Epitopes, B-Lymphocyte | 2 | 2021 | 1267 | 0.06 | Why? |
| Amino Acid Sequence | 2 | 2004 | 6049 | 0.06 | Why? |
| Sequence Analysis, RNA | 2 | 2021 | 2290 | 0.06 | Why? |
| Models, Biological | 1 | 2018 | 4907 | 0.05 | Why? |
| Enzyme-Linked Immunosorbent Assay | 3 | 2021 | 7868 | 0.05 | Why? |
| Immune Evasion | 2 | 2021 | 2081 | 0.05 | Why? |
| Sequence Homology, Amino Acid | 1 | 2003 | 945 | 0.05 | Why? |
| Mice, Inbred C57BL | 2 | 2021 | 5542 | 0.05 | Why? |
| Immunoglobulin Variable Region | 1 | 2021 | 253 | 0.05 | Why? |
| Pneumonia, Viral | 4 | 2021 | 243684 | 0.05 | Why? |
| Carrier Proteins | 1 | 2003 | 513 | 0.05 | Why? |
| Dependovirus | 1 | 2021 | 272 | 0.05 | Why? |
| Species Specificity | 1 | 2004 | 1356 | 0.05 | Why? |
| Coronavirus Infections | 4 | 2021 | 253789 | 0.05 | Why? |
| Protein Structure, Quaternary | 1 | 2021 | 455 | 0.05 | Why? |
| Cyclosporine | 1 | 2003 | 449 | 0.05 | Why? |
| T-Lymphocytes | 1 | 2017 | 6670 | 0.05 | Why? |
| Antigen-Antibody Reactions | 1 | 2021 | 616 | 0.05 | Why? |
| Macaca mulatta | 2 | 2021 | 3716 | 0.05 | Why? |
| Antigen-Antibody Complex | 1 | 2021 | 408 | 0.05 | Why? |
| Serogroup | 1 | 2020 | 510 | 0.04 | Why? |
| Fluorescent Antibody Technique | 1 | 2021 | 835 | 0.04 | Why? |
| Gene Editing | 1 | 2021 | 330 | 0.04 | Why? |
| Disease Models, Animal | 3 | 2021 | 10998 | 0.04 | Why? |
| Immunoblotting | 1 | 2017 | 180 | 0.04 | Why? |
| Aged | 7 | 2021 | 215776 | 0.04 | Why? |
| CD4 Antigens | 1 | 2017 | 306 | 0.04 | Why? |
| Immunophenotyping | 1 | 2020 | 1290 | 0.04 | Why? |
| Young Adult | 3 | 2021 | 93724 | 0.04 | Why? |
| Mesocricetus | 1 | 2021 | 1847 | 0.04 | Why? |
| Antibody Specificity | 1 | 2020 | 1328 | 0.04 | Why? |
| Lung | 2 | 2021 | 31049 | 0.04 | Why? |
| HLA Antigens | 1 | 2021 | 830 | 0.04 | Why? |
| Epitope Mapping | 1 | 2020 | 1240 | 0.04 | Why? |
| Body Weight | 1 | 2021 | 1074 | 0.04 | Why? |
| Intestines | 1 | 2021 | 817 | 0.03 | Why? |
| Adaptation, Physiological | 1 | 2017 | 359 | 0.03 | Why? |
| Polymerase Chain Reaction | 2 | 2021 | 6740 | 0.03 | Why? |
| Middle Aged | 6 | 2021 | 270681 | 0.03 | Why? |
| Crystallography, X-Ray | 1 | 2021 | 2689 | 0.03 | Why? |
| Time Factors | 3 | 2021 | 31397 | 0.03 | Why? |
| Radiography | 1 | 2021 | 1576 | 0.03 | Why? |
| Immunoglobulin M | 2 | 2021 | 9091 | 0.03 | Why? |
| Immunization, Secondary | 1 | 2021 | 1649 | 0.03 | Why? |
| Adult | 5 | 2021 | 244371 | 0.03 | Why? |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2020 | 877 | 0.03 | Why? |
| Female | 10 | 2021 | 380317 | 0.03 | Why? |
| CRISPR-Cas Systems | 1 | 2021 | 1397 | 0.03 | Why? |
| Biopsy | 1 | 2021 | 2811 | 0.03 | Why? |
| High-Throughput Screening Assays | 1 | 2020 | 1783 | 0.03 | Why? |
| Seroconversion | 1 | 2021 | 2515 | 0.03 | Why? |
| Leukocytes, Mononuclear | 1 | 2020 | 2115 | 0.03 | Why? |
| Mice, Inbred BALB C | 1 | 2021 | 5814 | 0.03 | Why? |
| Multivariate Analysis | 1 | 2021 | 5440 | 0.03 | Why? |
| Gene Expression Profiling | 1 | 2021 | 3788 | 0.02 | Why? |
| Convalescence | 1 | 2020 | 2829 | 0.02 | Why? |
| Flow Cytometry | 1 | 2017 | 2393 | 0.02 | Why? |
| Cross Reactions | 1 | 2020 | 4374 | 0.02 | Why? |
| Respiratory System | 1 | 2021 | 3213 | 0.02 | Why? |
| Antibody Formation | 1 | 2021 | 4038 | 0.02 | Why? |
| Pandemics | 4 | 2021 | 389249 | 0.02 | Why? |
| Male | 6 | 2021 | 367725 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2020 | 10017 | 0.02 | Why? |
| Immunocompromised Host | 1 | 2020 | 5150 | 0.02 | Why? |
| Population Surveillance | 1 | 2020 | 4967 | 0.02 | Why? |
| Phylogeny | 1 | 2021 | 13341 | 0.01 | Why? |
| Nasopharynx | 1 | 2021 | 10224 | 0.01 | Why? |
| Viral Load | 1 | 2021 | 15850 | 0.01 | Why? |
| Adolescent | 2 | 2021 | 86841 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2020 | 22971 | 0.01 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2020 | 8843 | 0.01 | Why? |
| Biomarkers | 1 | 2020 | 23361 | 0.01 | Why? |
| Cohort Studies | 1 | 2021 | 36005 | 0.01 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.01 | Why? |
| Treatment Outcome | 1 | 2021 | 51732 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2020 | 25144 | 0.01 | Why? |
| United States | 1 | 2020 | 46150 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.01 | Why? |
Bieniasz's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(205)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(288)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_